Bio-Process Systems Alliance (BPSA)’s Post

Two hours. Two sessions. Critical insights on single-use #biotech. This morning at the #BPSASummit25, delivered exactly what the industry needed to hear—insightful conversations on the economic outlook for single-use technology and the strategic shifts driving life sciences and biotech forward. We heard from leading experts including Eric Langer (BioPlan Associates, Inc.), Larry West (Aspen Alert), and Shaguna Punj (PwC), who brought clarity, data, and a forward-looking perspective to the challenges and opportunities shaping our sector. Eric Langer said it best: “The biopharma industry is very dynamic, and single-use plays a major role in its success.” Key takeaways that had everyone taking notes: • Single-use technology today is more strategic and critical than ever • The industry is returning to a demand for more efficiency —with increased automation, single-use systems, and continuous bioprocessing • Growth opportunities are substantial as the bioprocessing sector matures and biologics demand shows no signs of slowing • Adoption of #singleuse continues to accelerate • Bottom line: The data is clear—single-use isn’t a trend, it’s foundational to the future of #pharma and value creation across the industry The 2025 BPSA International Single-Use Summit continues to be a space where critical conversations drive innovation forward.